Tower Research Capital (TRC)’s Skye Bioscience SKYE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$45.7K Buy
10,927
+5,989
+121% +$25K ﹤0.01% 3049
2025
Q1
$7.85K Buy
4,938
+1,707
+53% +$2.71K ﹤0.01% 3928
2024
Q4
$9.14K Buy
3,231
+557
+21% +$1.58K ﹤0.01% 3935
2024
Q3
$10.5K Buy
+2,674
New +$10.5K ﹤0.01% 3754